Medco Spinoff Plan Revised; PBM Margins Look Healthier In 2003

The one-year delay in Merck's Medco spinoff means that the pharmacy benefit manager will begin operations as a separately traded public company with a healthier gross margin

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet